The early impact of vaccination against SARS-CoV-2 in Region Stockholm, Sweden.
COVID-19
Cohort study
Long-term-care-facilities
SARS-CoV2
Vaccines
Journal
Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899
Informations de publication
Date de publication:
03 05 2022
03 05 2022
Historique:
received:
12
08
2021
revised:
21
03
2022
accepted:
23
03
2022
pubmed:
9
4
2022
medline:
28
4
2022
entrez:
8
4
2022
Statut:
ppublish
Résumé
Vaccination against SARS-CoV-2 started in Region Stockholm, Sweden in December 2020 with those in long-term care facilities or receiving home care vaccinated first followed by those aged over 80 years. In this population-based, retrospective cohort study, we performed a Poisson regression to model the expected incidence of infections and deaths which we compared to the observed incidence and compared this to an unvaccinated control group of those aged 18-79 years. The aim of this study was to measure the early impact of the vaccination programme in Region Stockholm. Infections and deaths reduced substantially amongst the first two groups targeted for SARS-CoV-2 vaccination with an estimated total 3112 infections prevented, and 854 deaths prevented in these two groups from 4 weeks after the introduction of vaccination through to 2nd May 2021.
Identifiants
pubmed: 35393149
pii: S0264-410X(22)00372-3
doi: 10.1016/j.vaccine.2022.03.061
pmc: PMC8960184
pii:
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2823-2827Informations de copyright
Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.